We asked, you answered, we listened.
The most commonly requested topic by Psychedelic Medicine Association members is how psychedelic medicines can be used in end-of-life, hospice, and palliative care. And luckily, this is one of the areas in which research with psychedelics has been done and we have findings that we can put into practice.
At the end of a patient’s life, we know they may suffer not only the effects of the disease from which they are dying but also with the myriad of mental concerns they may have regarding death and dying.
Fortunately, a number of studies have taken a look at whether psychedelic therapies may be effective at mitigating some of the end-of-life anxiety patients often face, as well as addressing some of the mental health conditions that can stem from having a terminal illness, like depression.
This month we are truly fortunate to have some great minds in the hospice and end-of-life fields to help us better understand how psychedelics may be able to play a role in making this difficult time more comfortable for patients. They discussed the following:
- What kinds of psychedelic therapies have been studied in patients facing terminal illnesses
- How treatments were administered (individual vs. group)
- The results of the trials and the treatment programs
- What other psychedelic interventions may be helpful


